Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts and Legal Matters” and to the use of our report dated October 21, 2019 relating to the consolidated financial statement of BriaCell Therapeutics Corp. in the Registration Statement (Form F-1) and the related Prospectus of BriaCell Therapeutics Corp. dated October 22, 2019.

October 22, 2019	/s/ MNP LLP
	Chartered Professional Accountants
Mississauga, Ontario	Licensed Public Accountants